BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 30268659)

  • 1. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018.
    Cumberbatch MGK; Jubber I; Black PC; Esperto F; Figueroa JD; Kamat AM; Kiemeney L; Lotan Y; Pang K; Silverman DT; Znaor A; Catto JWF
    Eur Urol; 2018 Dec; 74(6):784-795. PubMed ID: 30268659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors.
    Jubber I; Ong S; Bukavina L; Black PC; Compérat E; Kamat AM; Kiemeney L; Lawrentschuk N; Lerner SP; Meeks JJ; Moch H; Necchi A; Panebianco V; Sridhar SS; Znaor A; Catto JWF; Cumberbatch MG
    Eur Urol; 2023 Aug; 84(2):176-190. PubMed ID: 37198015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, Screening, and Prevention of Bladder Cancer.
    Lobo N; Afferi L; Moschini M; Mostafid H; Porten S; Psutka SP; Gupta S; Smith AB; Williams SB; Lotan Y
    Eur Urol Oncol; 2022 Dec; 5(6):628-639. PubMed ID: 36333236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.
    Fernández MI; Brausi M; Clark PE; Cookson MS; Grossman HB; Khochikar M; Kiemeney LA; Malavaud B; Sanchez-Salas R; Soloway MS; Svatek RS; Vikram R; Vrieling A; Kamat AM
    World J Urol; 2019 Jan; 37(1):3-13. PubMed ID: 30105454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.
    Antoni S; Ferlay J; Soerjomataram I; Znaor A; Jemal A; Bray F
    Eur Urol; 2017 Jan; 71(1):96-108. PubMed ID: 27370177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology of and risk factors for bladder cancer and for urothelial tumors].
    Guillaume L; Guy L
    Rev Prat; 2014 Dec; 64(10):1372-4, 1378-80. PubMed ID: 25668830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and risk factors of urothelial bladder cancer.
    Burger M; Catto JW; Dalbagni G; Grossman HB; Herr H; Karakiewicz P; Kassouf W; Kiemeney LA; La Vecchia C; Shariat S; Lotan Y
    Eur Urol; 2013 Feb; 63(2):234-41. PubMed ID: 22877502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Occupational Carcinogen Exposure and Bladder Cancer: A Systematic Review and Meta-analysis.
    Cumberbatch MG; Cox A; Teare D; Catto JW
    JAMA Oncol; 2015 Dec; 1(9):1282-90. PubMed ID: 26448641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks.
    Cumberbatch MG; Rota M; Catto JW; La Vecchia C
    Eur Urol; 2016 Sep; 70(3):458-66. PubMed ID: 26149669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence.
    Baldacci S; Gorini F; Santoro M; Pierini A; Minichilli F; Bianchi F
    Epidemiol Prev; 2018; 42(3-4 Suppl 1):1-34. PubMed ID: 30066535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analyses of occupational exposure as a painter and lung and bladder cancer morbidity and mortality 1950-2008.
    Bachand A; Mundt KA; Mundt DJ; Carlton LE
    Crit Rev Toxicol; 2010; 40(2):101-25. PubMed ID: 20085479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder Cancer in Lebanon: Incidence and Comparison to Regional and Western Countries.
    Lakkis NA; Adib SM; Hamadeh GN; El-Jarrah RT; Osman MH
    Cancer Control; 2018; 25(1):1073274818789359. PubMed ID: 30027755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and etiology of bladder cancer.
    Cohen SM; Johansson SL
    Urol Clin North Am; 1992 Aug; 19(3):421-8. PubMed ID: 1636227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupational variation in bladder cancer in Nordic males adjusted with approximated smoking prevalence.
    Hadkhale K; Martinsen JI; Weiderpass E; Kjærheim K; Sparén P; Tryggvadóttir L; Lynge E; Pukkala E
    Acta Oncol; 2019 Jan; 58(1):29-37. PubMed ID: 30320536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of urothelial carcinoma.
    Miyazaki J; Nishiyama H
    Int J Urol; 2017 Oct; 24(10):730-734. PubMed ID: 28543959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies.
    Vineis P; Marinelli D; Autrup H; Brockmoller J; Cascorbi I; Daly AK; Golka K; Okkels H; Risch A; Rothman N; Sim E; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1249-52. PubMed ID: 11751441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contemporary landscape of occupational bladder cancer within the United Kingdom: a meta-analysis of risks over the last 80 years.
    Cumberbatch MG; Windsor-Shellard B; Catto JW
    BJU Int; 2017 Jan; 119(1):100-109. PubMed ID: 27332981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility study for interspecialistic collaboration in active research of urothelial neoplasms of professional origin.
    Stopponi R; Caraceni E; Marronaro A; Fabiani A; Massacesi S; Totò AR; Calisti R
    Arch Ital Urol Androl; 2018 Sep; 90(3):176-180. PubMed ID: 30362683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.